Picture of Genex Pharmaceutical logo

GENX Genex Pharmaceutical Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Genex Pharmaceutical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2003
December 31st
2004
December 31st
2005
December 31st
C2006
December 31st
2007
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10KSB10KSB10KSB10KSB10KSB
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line0.4511.010.6250.6190.343
Depreciation
Non-Cash Items00.0250.0060.603
Unusual Items
Other Non-Cash Items
Changes in Working Capital-1.07-0.9830.6660.5-0.472
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Payable / Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Cash from Operating Activities-0.6010.0891.381.180.53
Capital Expenditures-0.305-0.006-0.001-0.004-0.001
Purchase of Fixed Assets
Other Investing Cash Flow Items-1.29-1.88
Other Investing Cash Flow
Cash from Investing Activities-0.305-0.006-0.001-1.3-1.88
Financing Cash Flow Items0-1.420.0061.57
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Cash from Financing Activities1.150-1.420.0061.57
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.2420.084-0.03-0.1040.238